Pacific Biosciences Of California PACB
NASDAQ PACB
$1.29 -0.03 (-2.28%)
As of: Sep 9, 2026 · 3:59 PM EDT

Pacific Biosciences Of California (PACB) Sales of Property, Plant and Equipment (2015 - 2026)

Analysis

Pacific Biosciences Of California (PACB) Sales of Property, Plant and Equipment (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn 4.00 Mn
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn -
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn -
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn -
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn 3.04 Mn
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn -100,000.00
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn -
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn -
10 Pacific Biosciences Of California 400.74 Mn 163.87 Mn 12.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 50.00 Mn
Dec 31, 2017 39,000.00
Sep 30, 2017 -10,000.00
Jun 30, 2016 -101,000.00
Mar 31, 2016 111,000.00
Dec 31, 2015 24,000.00
Sep 30, 2015 6,000.00